Search Results

0 results for 'Novo Nordisk'

You can use to get even better search results Novo Nordisk
December 19, 2024 | The Legal Intelligencer

Ozempic MDL Expands to Include New Drugs, but Not New Injuries

"An MDL that encompassed any potential injury relating to use of these exceedingly popular weight loss drugs might quickly become procedurally and substantively unwieldy,” the Judicial Panel of Multidistrict Litigation ruled.
3 minute read
December 19, 2024 | Law.com

Five Noteworthy Litigation Trends of 2024—and What to Watch in 2025

With the potential to redefine key areas of the law, here are the five most interesting litigation hotspots spotted by Law.com Radar in 2024.
6 minute read
December 13, 2024 | New Jersey Law Journal

Litigation Surge: Drugmakers Launch Flood of Suits to Halt Generics

At least 29 patent suits were filed in the District of New Jersey in November, reflecting a jump from the rate of 18 suits per month in the period from December 2023 to November 2024. The multitude of suits include many that stem from generic drugmakers' plans to sell lower-priced versions of recognized pharmaceutical products.
4 minute read
November 25, 2024 | Daily Business Review

'Big Law Had Become Too Woke': Why Bill Barr Moved On

The former U.S. Attorney General headlined the Government Investigations & Civil Litigation Institute conference in Fort Lauderdale, Florida.
6 minute read
November 21, 2024 | National Law Journal

Holland & Knight, Akin, Crowell, Barnes and Day Pitney Add to DC Practices

In the latest round of lateral hiring in D.C., Holland & Knight, Day Pitney, Akin Gump, Barnes and Crowell announced new attorney hires this week.
3 minute read
October 18, 2024 | The Legal Intelligencer

Judge Shuts Down Efforts to Expand Scope of Discovery in Ozempic MDL

Judge Karen Marston held that, despite plaintiffs' arguments to the contrary, marketing discovery is not relevant to the broad legal issues the court has prioritized for early resolution.
3 minute read
October 16, 2024 | The Legal Intelligencer

Ozempic Plaintiffs Push for Marketing Discovery After MDL Judge Imposes Limits

"These are not case-specific issues," the plaintiffs contended. "The marketing was national in scale and magnitude, and everything that occurred with regard to these drugs over the last several years is in some way tethered to the marketing."
4 minute read
October 04, 2024 | Texas Lawyer

4 Law Firms Back Texas AG Suit on Insulin Price-Gouging Allegations

The state alleges this insulin pricing scheme violates the Texas Deceptive Trade Practices Act, constitutes unjust enrichment, and represents an unlawful civil conspiracy.
4 minute read
September 20, 2024 | National Law Journal

FTC Takes Legal Action Against Three Largest PBMs Over High Insulin Prices

"Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug costs have skyrocketed over the past decade thanks in part to powerful PBMs and their greed," said Rahul Rao, deputy director of the FTC's Bureau of Competition.
6 minute read

Resources

  • Why Embracing Change Is Essential for Your Legal Department

    Brought to you by DiliTrust

    Download Now

  • International Export and Trade Assistance State Law Survey

    Brought to you by LexisNexis®

    Download Now

  • How This Personal Injury Firm Reduced Client Intake Time by 80%

    Brought to you by PracticePanther

    Download Now

  • The Hidden Cost of Bad Reviews: Why Law Firms & Attorneys Can't Afford a Damaged Online Reputation

    Brought to you by Erase.com

    Download Now